Form 8-K - Current report:
SEC Accession No. 0001104659-25-011543
Filing Date
2025-02-11
Accepted
2025-02-11 17:00:21
Documents
15
Period of Report
2025-02-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm255980d2_8k.htm   iXBRL 8-K 50898
2 EXHIBIT 3.1 tm255980d2_ex3-1.htm EX-3.1 8163
3 EXHIBIT 10.2 tm255980d2_ex10-2.htm EX-10.2 471129
  Complete submission text file 0001104659-25-011543.txt   820036

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA twst-20250205.xsd EX-101.SCH 3036
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE twst-20250205_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE twst-20250205_pre.xml EX-101.PRE 22373
17 EXTRACTED XBRL INSTANCE DOCUMENT tm255980d2_8k_htm.xml XML 3670
Mailing Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 800-719-0671
Twist Bioscience Corp (Filer) CIK: 0001581280 (see all company filings)

EIN.: 462058888 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38720 | Film No.: 25610687
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)